Chrysoula Belessi

Hematology Department, Nikea General Hospital

Research Area

Biography

Chrysoula Belessi has not added Biography.
If you are Chrysoula Belessi and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 14	2018

Other Publications

Article	Year
Immunoglobulin heavy- and light-chain repertoire in splenic marginal zone lymphoma. Molecular medicine (Cambridge, Mass.)\| PubMed ID: 15706403	2004
Analysis of expressed and non-expressed IGK locus rearrangements in chronic lymphocytic leukemia. Molecular medicine (Cambridge, Mass.)\| PubMed ID: 16622520	2005
IGHV gene insertions and deletions in chronic lymphocytic leukemia: "CLL-biased" deletions in a subset of cases with stereotyped receptors. European journal of immunology\| PubMed ID: 16783849	2006
Activation-induced cytidine deaminase splicing patterns in chronic lymphocytic leukemia. Blood cells, molecules & diseases\| PubMed ID: 20117026	2010
Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients. Haematologica\| PubMed ID: 21750087	2011
Partial versus productive immunoglobulin heavy locus rearrangements in chronic lymphocytic leukemia: implications for B-cell receptor stereotypy. Molecular medicine (Cambridge, Mass.)\| PubMed ID: 21968789	2012
Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies. Blood\| PubMed ID: 22415752	2012
Distinct innate immunity pathways to activation and tolerance in subgroups of chronic lymphocytic leukemia with distinct immunoglobulin receptors. Molecular medicine (Cambridge, Mass.)\| PubMed ID: 22437326	2012
Differential microRNA profiles and their functional implications in different immunogenetic subsets of chronic lymphocytic leukemia. Molecular medicine (Cambridge, Mass.)\| PubMed ID: 23615967	2013
IgG-switched CLL has a distinct immunogenetic signature from the common MD variant: ontogenetic implications. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 24240110	2014
Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting. Haematologica\| PubMed ID: 25480502	2015
Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations. Blood\| PubMed ID: 25634617	2015
Molecular evidence for antigen drive in the natural history of mantle cell lymphoma. The American journal of pathology\| PubMed ID: 25843681	2015
Toll-like receptor stimulation in splenic marginal zone lymphoma can modulate cell signaling, activation and proliferation. Haematologica\| PubMed ID: 26294727	2015
An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 26647217	2016
Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study. The Lancet. Haematology\| PubMed ID: 27030157	2014
B Cell Anergy Modulated by TLR1/2 and the miR-17∼92 Cluster Underlies the Indolent Clinical Course of Chronic Lymphocytic Leukemia Stereotyped Subset #4. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 27059597	2016
Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors. Haematologica\| PubMed ID: 27198719	2016
Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 28536306	2017
No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy. Haematologica\| PubMed ID: 29269523	2018
Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia. Haematologica\| PubMed ID: 30262567	2018
Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia. International journal of cancer\| PubMed ID: 30447004	2018
Automated shape-based clustering of 3D immunoglobulin protein structures in chronic lymphocytic leukemia. BMC bioinformatics\| PubMed ID: 30453883	2018